Back to ACAD
DekaBank Deutsche Girozentrale → ACAD
DekaBank Deutsche Girozentrale ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
9
Latest value
$2M
Q3 2026
Peak value
$2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $154K |
| Q3 2025 | $1.9M |
| Q4 2025 | $135K |
| Q4 2025 | $1.7M |
| Q1 2026 | $162K |
| Q1 2026 | $2M |
| Q2 2026 | $159K |
| Q2 2026 | $2M |
| Q3 2026 | $2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $2M | 95.4K | — | — |
| Q2 2026 | $2M | 90.0K | — | — |
| Q2 2026 | $159K | 7.3K | — | — |
| Q1 2026 | $2M | 90.0K | — | — |
| Q1 2026 | $162K | 7.3K | — | — |
| Q4 2025 | $1.7M | 90.0K | — | — |
| Q4 2025 | $135K | 7.3K | — | — |
| Q3 2025 | $1.9M | 90.0K | — | — |
| Q3 2025 | $154K | 7.3K | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M
$211.3M
$202.4M